BioStem secures USD 40 million equity facility via private placement with Roth affiliate

Bitget2026/09/18 11:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

BioStem Technologies entered a committed equity facility for up to USD 40 million with Roth Principal Investments via a private placement.
Facility lets BioStem sell common stock to Roth at its discretion, subject to conditions including an effective resale registration statement.
Issuance is capped at 19.99% of shares outstanding at signing unless shareholder approval is obtained or Nasdaq minimum-price rules are met.
Net proceeds are intended for working capital, general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biostem Technologies Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609180700PRIMZONEFULLFEED9829451) on September 18, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

BioStem secures USD 40 million equity facility via private placement with Roth affiliate

You may also like

Crypto prices